More Business Wire
View Older Stories View Newer Stories-
AMC Entertainment Holdings, Inc. Announces First Lien Notes Offering and Conditional Notice of Redemption for Existing Odeon Notes
-
AMC Entertainment Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
-
Dominion Energy announces 2025 financial results
-
Starlab Completes NASA Commercial Critical Design Review
-
Stanley Martin Homes to Acquire United Homes Group
-
Guala Closures Expands Manufacturing Footprint in Mexico to Support U.S. Wine and Spirits Market
-
ProCap Financial Commences Aggressive Share Buyback Program and Commits to Working to Close the Discount to NAV
-
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
-
Gibraltar Sells Renewables Electrical Balance of Systems (eBOS) Business to GameChange Energy Technologies for $70 Million
-
Cannae Holdings, Inc. Announces Quarterly Cash Dividend of $0.15
-
CenterPoint Energy, Inc. Announces Offering of $550 Million of Convertible Senior Notes Due 2029
-
Herbalife Plans to Refinance Senior Secured Debt
-
FHLBank Chicago and Spring Bank Award Grants to Strengthen Affordable Housing Talent Pipeline in Milwaukee and Increase Housing Supply
-
Blackstone Life Sciences Announces a Co-Funding Agreement for Acute Myeloid Leukemia
-
PENN Entertainment Appoints Three New Independent Directors to Board
-
Dream Finders Announces Fourth Quarter and Full Year 2025 Results
-
ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally
-
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
-
ACCO Brands Corporation Announces Fourth Quarter and Full Year 2025 Earnings Webcast
-
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
-
SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology
-
Amica Celebrates Jayson Tatum’s Road to Recovery With New Ad Campaign, ‘Back to Zero’
-
Sherpas Raises $3.2M Seed Round to Scale the AI Operating Layer for Wealth Management
-
Picsart Launches Aura - Delivering Social Content and Short-Form Videos in Minutes
-
SS&C GlobeOp Forward Redemption Indicator
-
Flaus, the World’s Best Electric Flosser and Now the Only Clinically Backed Electric Flosser on the Market, Completes Successful Clinical Trials, Proving That It Removes More Plaque Between Teeth Th
-
Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team
-
Core Scientific, Inc. Schedules Fourth Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast
-
Triumph to Present at the Raymond James 47th Annual Institutional Investors Conference on March 3, in Orlando, FL
-
Smiths Detection equips El Salvador Customs with state-of-the-art X-ray scanners to deliver fast and reliable screening
-
Qatar Investment Authority and 5C Investment Partners Announce Strategic Private Credit Partnership
-
Canada Goose Announces Participation in 47th Raymond James Institutional Investor Conference
-
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
-
Northisle Included in BC’s Critical Minerals Office
-
Lumen Ratings Upgraded by Top 3 Global Ratings Agencies
-
Merck Evolves Human Health Operating Structure to Support Portfolio Execution
-
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
-
Easterly Government Properties Reports Fourth Quarter 2025 Results
-
lululemon Announces 100th Store Opening in EMEA
-
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026
-
GeoPark Comments on Parex Resources’ Nomination of Director Candidates
-
Calix Postpones 2026 Investor Day Due to Weather Event
-
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
-
Airgain Secures Multi‑Year, Multi‑Million Dollar Design Win for Tier‑1 MNO 5G Home Connectivity Platform
-
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
-
Lenovo Unlocks Data Potential with Next Generation of AI-Driven ThinkEdge Solutions
-
Starfighters Space Founder Rick Svetkoff Steps Down after Listing on NYSE; Tim Franta Appointed as CEO
-
Emera Reports 2025 Fourth Quarter Financial and Annual Financial Results, Extends Growth Target
